![]() |
市場調查報告書
商品編碼
1828140
2025年全球腹腔鏡設備市場報告Laparoscopy Devices Global Market Report 2025 |
近年來,腹腔鏡器械市場呈現強勁成長勢頭,市場規模從2024年的127.5億美元成長至2025年的134.9億美元,複合年成長率為5.8%。預測期內的成長可歸因於外科醫生培訓計畫的改進、安全性和有效性的提高、向微創手術的轉變、能量器械的演變以及早期應用的挑戰。
預計未來幾年腹腔鏡設備市場規模將強勁成長,到2029年將達到183.9億美元,複合年成長率為8.1%。預測期內的成長可歸因於客製化和以患者為中心的理念、新興國家的市場滲透、培訓和技能發展項目、機器人輔助系統的整合以及能源型設備的成長。預測期內的主要趨勢包括設備小型化、微創手術的興起、新興國家的採用、對培訓和教育的重視以及機器人技術的整合。
腹腔鏡設備由帶有伸縮桿透鏡系統的硬式內視鏡組成,通常連接到單頭或三頭攝影機。這些設備使外科醫生無需進行大面積皮膚切口即可進入腹部和骨盆區域。
腹腔鏡器械的主要類型包括腹腔鏡、能量器械、氣腹器械、機器人輔助手術系統、吸引或沖洗系統、閉合器械、手持器械、介入性器械及其配件。例如,腹腔鏡是一種小型管狀醫療設備,配有照明燈、鏡頭和用於組織切除的工具。它可用於各種外科手術,例如一般外科、減重手術和婦科手術,並被包括醫院和診所在內的各種終端用戶使用。
2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療設備產業產生了重大影響,尤其對影像處理設備、手術用不銹鋼和一次性塑膠等進口零件產生了重大影響。由於醫院和診所抵制漲價,製造商面臨利潤壓力。監管挑戰使情況更加複雜,因為由於關稅而更換供應商通常需要醫療設備重新認證,導致市場進入延遲。為此,企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。
本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分,該系列提供腹腔鏡設備市場統計數據,包括全球市場規模、區域佔有率、腹腔鏡設備市場佔有率競爭對手、詳細的腹腔鏡設備細分市場、市場趨勢和商機,以及您在腹腔鏡設備行業取得成功所需的數據。本腹腔鏡設備市場研究報告對該行業的現狀和未來趨勢進行了詳細分析,為您提供所需的一切觀點。
未來五年8.1%的預測成長率比我們先前對該市場的預測略有下降,下降了0.2%。下降的主要原因是美國與其他國家之間關稅的影響。這種影響可能會直接波及美國,導致5毫米套管針組件和高清攝影機成像晶片的供應鏈中斷,這些組件來自法國和以色列等關鍵地區,這可能導致微創手術的延誤和腹部手術成本的增加。由於互惠關稅以及貿易緊張局勢和限制措施升級對全球經濟和貿易的負面影響,這種影響也可能更為廣泛。
慢性病盛行率的上升預計將推動未來腹腔鏡設備市場的擴張。慢性病的特徵是持續一年以上、需要持續治療且常常限制日常活動的健康問題。這類疾病的例子包括心臟病、癌症、肥胖和糖尿病。腹腔鏡檢查可以為患有未確診的慢性腹痛的患者提供準確的診斷和治療性介入。此外,研究表明,這些設備有助於微創外科手術。根據美國心臟學會 2022 年 8 月發布的報告,預計 2025 年至 2060 年間美國所有四大心血管危險因子都將增加。預計增幅最大的是糖尿病,增加 39.3% 至 5,500 萬人,其次是血脂異常症(增加 27.6% 至 1.26 億人)、高血壓(增加 25.1% 至 1.62 億人)和肥胖(增加 18.3% 至 1.26 億人)。此外,心血管疾病患者數量預計將大幅增加,包括中風(增加33.8%,達到1500萬人)和心臟衰竭(增加33.4%,達到1300萬人)。缺血性心臟疾病(成長30.7%,達2,900萬人)和心臟病發作(成長16.9%,達1,600萬人)也將大幅增加。因此,慢性病盛行率的上升將成為腹腔鏡設備市場成長的關鍵因素。
由於肥胖症的日益普遍,腹腔鏡設備市場也預計將成長。肥胖症是指體內脂肪堆積過多,身體質量指數 (BMI) 達到或超過 30,會對健康造成重大風險。腹腔鏡設備通常用於肥胖患者的微創手術,可減少術後併發症並加速復原速度。截至 2022 年 3 月,世界衛生組織 (WHO) 報告稱,肥胖影響了超過 10 億人,其中包括 6.5 億成年人、3.4 億青少年和 3,900 萬名兒童。預計這一數字將繼續成長,到 2025 年,估計將有 1.67 億人因超重或肥胖而健康狀況不佳。因此,肥胖症的日益普遍推動了腹腔鏡設備市場的發展。
腹腔鏡設備市場的主要企業正致力於開發先進的能量系統,以改善手術效果並提高手術效率。這些創新的能量設備融合了最尖端科技和多功能性,對於腹腔鏡手術至關重要。例如,2022 年 9 月,致力於創造疾病檢測、預防和治療解決方案的日本醫療技術公司Olympus Corporation推出了專為開放手術設計的手術能量設備 THUNDERBEAT 開放性手術 Jaw Type X。該設備將先進的能量輸送與精確的組織操作相結合,以促進有效的解剖和凝固。其設計最大限度地減少了熱量擴散,同時提高了手術效率,使其在精度和控制是成功關鍵的腹腔鏡手術中特別有用。
腹腔鏡設備市場的主要企業正專注於開發先進的視覺化系統,以提高手術精度並改善臨床效果。高清影像解決方案,尤其是將3D視覺化與直覺功能結合的解決方案,對於腹腔鏡手術至關重要。例如,2023年5月,德國醫療保健公司B.Braun推出了AESCULAP EinsteinVision 3.0 FI系統。該系統透過先進的3D螢光成像功能改進了腹腔鏡手術,可即時可視化血管和膽管等關鍵結構。內建防霧技術可確保手術過程中的清晰視野,多種螢光疊加模式可靈活評估組織灌注和解剖結構。透過促進微創干預過程中的精確導航和決策,該系統顯著縮短了手術時間並改善了手術效果。
2023年6月,總部位於愛爾蘭、專注於感染預防、消毒和外科產品的STERIS plc公司以5.4億美元收購了Becton, Dickinson & Co.的外科器械資產。此次收購增強了STERIS的外科解決方案組合,尤其專注於擴大其高品質外科器械的選擇範圍,以滿足醫療專業人士的需求。 Becton, Dickinson & Co.是一家總部位於美國的腹腔鏡設備供應商。
腹腔鏡設備市場的主要企業包括 B. Braun Melsungen AG、Boston Scientific Corporation、CONMED Corporation、Ethicon Inc.、Karl Storz SE &Co.KG、Medtronic PLC、Olympus Corporation、Richard Wolf GmbH、Smith & Nephew PLC、Stryker Corporation、Intuitive Surgical Corporation Inc.、The Cooperm. Ltd.、Applied Medical Resources Corporation、Cooper Surgical Inc、 FUJIFILM Holdings Corporation、Grena Ltd.、Henke-Sass Wolf GmbH、LaproSurge Ltd.、Maxer Endoscopy GmbH、MedGyn Products Inc.、EndoOptiks Inc.、EndoChoice Inc.、Endo-TechTech W. Glence G LiNA Medical ApS。
2024年,北美是腹腔鏡設備市場最大的地區。根據全球腹腔鏡設備市場報告,預計亞太地區將在預測期內成為成長最快的地區。腹腔鏡設備市場報告涵蓋亞太地區、西歐、中歐和東歐、北美、南美以及中東和非洲。
腹腔鏡設備市場報告涵蓋的國家包括澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、英國、美國、加拿大、義大利和西班牙
腹腔鏡設備市場包括腹腔鏡剪、抓取器、針柄、分離器和牽開器的銷售。該市場的價值為“出廠價”,即商品製造商或生產商銷售給其他營業單位(包括下游製造商、批發商、經銷商和零售商)或直接銷售給最終客戶的商品價值。該市場商品的價值還包括商品製造商銷售的任何相關服務。
Laparoscopy devices are comprised of rigid endoscopes equipped with telescopic rod lens systems, typically connected to single-chip or three-chip video cameras. These devices enable surgeons to access the abdominal and pelvic regions without the need for significant skin incisions.
The primary types of laparoscopy devices include laparoscopes, energy devices, insufflators, robot-assisted surgery systems, suction or irrigation systems, closure devices, hand instruments, access devices, accessories, and others. Laparoscopes, for instance, are small, tube-shaped medical devices featuring a light, a lens, and an instrument for tissue removal. They find applications in various surgical procedures, including general surgery, bariatric surgery, and gynecological surgery, and are utilized by diverse end users such as hospitals, clinics, and others.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.
The laparoscopy devices market research report is one of a series of new reports from The Business Research Company that provides laparoscopy devices market statistics, including laparoscopy devices industry global market size, regional shares, competitors with a laparoscopy devices market share, detailed laparoscopy devices market segments, market trends and opportunities, and any further data you may need to thrive in the laparoscopy devices industry. This laparoscopy devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The laparoscopy devices market size has grown strongly in recent years. It will grow from $12.75 billion in 2024 to $13.49 billion in 2025 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to improved surgeon training programs, enhanced safety and efficacy, shift towards minimally invasive surgery, evolution in energy-based devices, early adoption challenges.
The laparoscopy devices market size is expected to see strong growth in the next few years. It will grow to $18.39 billion in 2029 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to customization and patient-centric approach, market penetration in emerging economies, training and skill enhancement programs, integration of robotic-assisted systems, growth in energy-based devices. Major trends in the forecast period include miniaturization of devices, rise in minimally invasive surgeries, adoption in emerging economies, focus on training and education, integration of robotics.
The forecast of 8.1% growth over the next five years indicates a slight reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for 5mm trocar assemblies and high definition (HD) camera imaging chips, sourced from key regions such as France and Israel, which could lead to delayed minimally invasive surgeries and increased costs for abdominal procedures.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The rising incidence of chronic diseases is projected to drive the expansion of the laparoscopy devices market in the future. Chronic diseases are characterized as health issues that persist for a year or more, requiring ongoing medical treatment and often limiting daily activities. Examples of such diseases include heart disease, cancer, obesity, and diabetes. Laparoscopy can provide patients suffering from undiagnosed chronic abdominal pain with accurate diagnoses and therapeutic interventions. Additionally, research indicates that these devices facilitate minimally invasive surgical techniques. A report released by the American College of Cardiology in August 2022 highlighted that all four major cardiovascular risk factors in the United States are expected to rise between 2025 and 2060. The most significant increase is anticipated in diabetes, with a 39.3% rise to 55 million individuals, followed by dyslipidemia (27.6% to 126 million), hypertension (25.1% to 162 million), and obesity (18.3% to 126 million). Furthermore, notable increases in cardiovascular disease rates are expected, including a 33.8% rise in stroke cases (up to 15 million) and a 33.4% increase in heart failure (up to 13 million). Ischemic heart disease (up 30.7% to 29 million) and heart attack (up 16.9% to 16 million) will also see significant growth. Consequently, the rising prevalence of chronic diseases is a key factor in the growth of the laparoscopy devices market.
The laparoscopy devices market is also set to grow owing to the increasing prevalence of obesity. Obesity, a condition marked by excessive body fat accumulation and defined by a body mass index (BMI) of 30 or higher, poses significant health risks. Laparoscopy devices are commonly employed in minimally invasive surgical procedures for obese individuals, resulting in reduced postoperative complications and faster recovery. As of March 2022, the World Health Organization reported that over 1 billion people globally, including 650 million adults, 340 million adolescents, and 39 million children, were affected by obesity. This number continues to rise, with an estimated 167 million people experiencing deteriorating health due to being overweight or obese by 2025. Hence, the laparoscopy devices market is propelled by the increasing prevalence of obesity.
Leading companies in the laparoscopy devices market are focused on developing advanced energy systems to improve surgical outcomes and enhance procedural efficiency. These innovative energy devices, which integrate state-of-the-art technology with versatility, are essential for laparoscopic surgeries. For example, in September 2022, Olympus Corporation, a Japanese medical technology firm dedicated to creating solutions for disease detection, prevention, and treatment, introduced the THUNDERBEAT Open Fine Jaw Type X surgical energy devices designed for open surgery. This device combines advanced energy delivery with precise tissue manipulation, facilitating effective dissection and coagulation. Its design enhances surgical efficiency while minimizing thermal spread, making it especially valuable in laparoscopic procedures, where precision and control are critical for achieving successful results.
Prominent companies in the laparoscopy devices market are focusing on the development of advanced visualization systems to boost surgical precision and enhance clinical outcomes. High-definition imaging solutions, particularly those that combine 3D visualization with intuitive features, are essential for laparoscopic procedures. For example, in May 2023, B. Braun, a healthcare company based in Germany, introduced the AESCULAP EinsteinVision 3.0 FI system. This system improves laparoscopic surgeries through its advanced 3D fluorescence imaging capabilities, enabling real-time visualization of critical structures like blood vessels and bile ducts. Its built-in anti-fog technology ensures a clear view throughout the procedure, while various fluorescence overlay modes offer flexibility in assessing tissue perfusion and anatomy. By facilitating accurate navigation and decision-making during minimally invasive interventions, this system significantly reduces operating times and enhances surgical outcomes.
In June 2023, STERIS plc, an Ireland-based provider specializing in infection prevention, decontamination, and surgical products, completed the acquisition of surgical instrumentation assets from Becton, Dickinson, and Company for $540 million. This acquisition was intended to enhance STERIS's portfolio in surgical solutions, with a particular emphasis on broadening its selection of high-quality surgical instruments to better meet the needs of healthcare providers. Becton, Dickinson, and Company is a US-based company that supplies laparoscopy devices.
Major companies operating in the laparoscopy devices market include B. Braun Melsungen AG, Boston Scientific Corporation, CONMED Corporation, Ethicon Inc., Karl Storz SE & Co. KG, Medtronic PLC, Olympus Corporation, Richard Wolf GmbH, Smith & Nephew PLC, Stryker Corporation, Intuitive Surgical Inc., The Cooper Companies Inc., Microline Surgical Inc., Becton Dickinson and Company, Welfare Medical Ltd., Applied Medical Resources Corporation, Cooper Surgical Inc., Fujifilm Holdings Corporation, Grena Ltd., Henke-Sass Wolf GmbH, LaproSurge Ltd., Maxer Endoscopy GmbH, MedGyn Products Inc., EndoOptiks Inc., EndoChoice Inc., Endo-Technik W. Griesat GmbH, Endo-Flex GmbH, Endo-Therapeutics Inc., Smiths Group plc, LiNA Medical ApS
North America was the largest region in the laparoscopy devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global laparoscopy devices market report during the forecast period. The regions covered in the laparoscopy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the laparoscopy devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The laparoscopy devices market consists of sales of laparoscopic scissors, graspers, needle handles, dissectors, and retractors. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Laparoscopy Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on laparoscopy devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for laparoscopy devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The laparoscopy devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.